Latest Exploration Partnerships News

Peppermint Innovation Ltd has raised A$500,000 to accelerate the rollout of its bizmoto digital wallet platform across the Philippine cooperative sector, targeting millions of members and aiming to boost transaction frequency and recurring revenue.

Race Oncology has raised $3.22 million through a private placement to fund its HARNESS-1 Phase 1a/b trial targeting non-small cell lung cancer, with patient enrolment expected early next year.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.

Aeris Resources reported solid FY25 results within guidance and secured $80 million in new equity to fund exploration and development projects, positioning itself for significant growth in FY26.

EnergyX’s share price hike to US$11 signals renewed investor confidence and a lithium market rebound, increasing Pantera Lithium’s holding value by A$5.4 million.

Arcadia Minerals has secured a binding farm-in agreement with Kaoko Metals for its Karibib Copper Gold Project, unlocking immediate cash and future equity incentives while advancing exploration partnerships across its Namibian portfolio.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

Race Oncology has filed pivotal patents on the active (E,E)-bisantrene isomer, potentially extending its drug exclusivity by two decades, while advancing its Phase 1 clinical trial and maintaining a strong cash position.

Swift Networks has locked in key contracts with Australia's largest Aged Care provider and Chevron, while progressing its Swift TV rollout on track for Q3 FY26. The company also completed a $2.2 million capital raise, positioning itself for growth in new markets.

Syrah Resources resumed graphite production at its Balama mine and advanced its Vidalia anode material facility amid supportive US trade tariffs and tax credits, positioning itself strongly in the growing EV battery market.

Global Health Limited has accelerated its MasterCare+ SaaS platform rollout, integrating AI to streamline operations and reduce staff by 10%, while reporting a 25% EBIT improvement despite a delayed R&D refund impacting cash flow.

Race Oncology showcased compelling preclinical data at ESMO 2025 revealing that their drug RC220, combined with doxorubicin, not only shields the heart from toxicity but also boosts anticancer effects, supporting ongoing clinical trials.